Bareford D, Bailey C C, Robinson E A
Scand J Haematol. 1985 Sep;35(3):329-32. doi: 10.1111/j.1600-0609.1985.tb01714.x.
16 children with acute lymphoblastic leukaemia (ALL) who relapsed on maintenance treatment between September 1978 and December 1981 were studied. Their previous bone marrow aspirates were reviewed to determine the first evidence for marrow relapse and the subsequent rate of evolution of the disease. 60% of children had bone marrow evidence of unsuspected relapse at 8 wk, and 40% had evidence at 12 wk before clinical or peripheral blood relapse occurred. Early detection of relapse will prevent continued use of ineffective maintenance chemotherapy and may also reduce morbidity during subsequent induction therapy. Regular 8-weekly marrow aspirates are therefore recommended during first remission of ALL in children with a histocompatible sibling who would be eligible for bone marrow transplantation in second remission.
对1978年9月至1981年12月期间在维持治疗中复发的16例急性淋巴细胞白血病(ALL)患儿进行了研究。回顾他们之前的骨髓穿刺结果,以确定骨髓复发的首个证据以及疾病随后的进展速度。60%的患儿在8周时出现未被怀疑的骨髓复发证据,40%的患儿在临床或外周血复发前12周出现证据。早期发现复发将避免继续使用无效的维持化疗,还可能降低后续诱导治疗期间的发病率。因此,对于有组织相容性同胞且在第二次缓解期有资格接受骨髓移植的ALL患儿,建议在首次缓解期每8周定期进行骨髓穿刺。